Author:
Sureda Anna,Pennisi Martina,Corradini Paolo
Publisher
Springer International Publishing
Reference77 articles.
1. Horning SJ, Hoppe RT, Breslin S, Bartlett NL, Brown BW, Rosenberg SA (2002) Stanford V and radiotherapy for locally extensive and advanced Hodgkin disease: mature results of a prospective clinical trial. J Clin Oncol 20:630–637
2. Diehl V, Franklin J, Pfreundschuh M et al (2003) Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin disease. N Engl J Med 348:2386–2395
3. Linch DC, Winfield D, Goldstone AH et al (1993) Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin disease: results of a BNLI randomised trial. Lancet 341:1050–1054
4. Schmitz N, Pfistner B, Sextro M et al (2002) Aggressive conventional chemotherapy compared with high dose chemotherapy with autologous haematopoietic stem cell transplantation for relapsed chemosensitive Hodgkin disease: a randomised trial. Lancet 359:2065–2071
5. Sureda A, Arranz R, Iriondo A et al (2001) Autologous stem cell transplantation for Hodgkin disease: results and prognostic factors in 494 patients from the Grupo Español de Linfomas/Transplante Autólogo de Médula Ósea Spanish cooperative group. J Clin Oncol 19:1395–1404